[Inhibitors of angiotensin-converting enzyme in the treatment of arterial hypertension].
D000818:Animals; D002216:Captopril / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D004347:Drug Interactions; D004791:Enzyme Inhibitors / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D009842:Oligopeptides / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D007703:Peptidyl-Dipeptidase A / Q000378:metabolism*; D013722:Teprotide
D004791:Enzyme Inhibitors; D009842:Oligopeptides; D002216:Captopril; D013722:Teprotide; D007703:Peptidyl-Dipeptidase A
Gli inibitori dell'enzima di conversione dell'angiotensina nel trattamento dell'ipertensione arteriosa.